Literature DB >> 15308622

Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells.

Ningyu Chen1, Shr-Jeng Leu, Viktor Todorovic, Stephen C-T Lam, Lester F Lau.   

Abstract

CCN1 (CYR61) is a matricellular inducer of angiogenesis essential for successful vascular development. Though devoid of the canonical RGD sequence motif recognized by some integrins, CCN1 binds to, and functions through integrin alphavbeta3 to promote pro-angiogenic activities in activated endothelial cells. In this study we identify a 20-residue sequence, V2 (NCKHQCTCIDGAVGCIPLCP), in domain II of CCN1 as a novel binding site for integrin alphavbeta3. Immobilized synthetic V2 peptide supports alphavbeta3-mediated cell adhesion; soluble V2 peptide inhibits endothelial cell adhesion to CCN1 and the homologous family members CCN2 (connective tissue growth factor, CTGF) or CCN3 (NOV) but not to collagen. These activities are obliterated by mutation of the aspartate residue in the V2 peptide to alanine. The corresponding D125A mutation in the context of the N-terminal half of CCN1 (domains I and II) greatly diminished direct solid phase binding to purified integrin alphavbeta3 and abolished alphavbeta3-mediated cell adhesion activity. Likewise, soluble full-length CCN1 with the D125A mutation is defective in binding purified alphavbeta3 and impaired in alphavbeta3-mediated pro-angiogenic activities in vascular endothelial cells, including stimulation of cell migration and enhancement of DNA synthesis. In contrast, immobilized full-length CCN1-D125A mutant binds alphavbeta3 and supports alphavbeta3-mediated cell adhesion similar to wild type CCN1. These results indicate that V2 is the primary alphavbeta3 binding site in soluble CCN1, whereas additional cryptic alphavbeta3 binding site(s) in the C-terminal half of CCN1 becomes exposed when the protein is immobilized. Together, these results identify a novel and functionally important binding site for integrin alphavbeta3 and provide a new approach for dissecting alphavbeta3-specific CCN1 functions both in cultured cells and in the organism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308622     DOI: 10.1074/jbc.M406813200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Extracellular matrix associated protein CYR61 is linked to prostate cancer development.

Authors:  Katherine B D'Antonio; Antoun Toubaji; Roula Albadine; Alison M Mondul; Elizabeth A Platz; George J Netto; Robert H Getzenberg
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

2.  CCN1 promotes vascular endothelial growth factor secretion through αvβ 3 integrin receptors in breast cancer.

Authors:  Ingrid Espinoza; Javier A Menendez; Chandra Mohan Kvp; Ruth Lupu
Journal:  J Cell Commun Signal       Date:  2013-12-12       Impact factor: 5.782

3.  Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors.

Authors:  N Habel; M Vilalta; O Bawa; P Opolon; J Blanco; O Fromigué
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

4.  CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease.

Authors:  Sarah K Johnson; James P Stewart; Rakesh Bam; Pingping Qu; Bart Barlogie; Frits van Rhee; John D Shaughnessy; Joshua Epstein; Shmuel Yaccoby
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

Review 5.  CCN1/CYR61: the very model of a modern matricellular protein.

Authors:  Lester F Lau
Journal:  Cell Mol Life Sci       Date:  2011-07-31       Impact factor: 9.261

Review 6.  The role of the CCN family of proteins in female reproduction.

Authors:  Elke Winterhager; Alexandra Gellhaus
Journal:  Cell Mol Life Sci       Date:  2014-01-22       Impact factor: 9.261

7.  Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61.

Authors:  Nicholas Young; Dennis K Pearl; James R Van Brocklyn
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

Review 8.  G protein-coupled receptors go extracellular: RhoA integrates the integrins.

Authors:  Colin T Walsh; Dwayne Stupack; Joan Heller Brown
Journal:  Mol Interv       Date:  2008-08

9.  The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Cell Biol       Date:  2010-06-06       Impact factor: 28.824

10.  Domain-and species-specific monoclonal antibodies recognize the Von Willebrand Factor-C domain of CCN5.

Authors:  Lan Wei; Frank McKeon; Joshua W Russo; Joan Lemire; John Castellot
Journal:  J Cell Commun Signal       Date:  2009-04-29       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.